|
|
 | | | |
- close
- close
- close
- close
Helix Biopharma Corp (HBP) |
QUOTE AND NEWS
Marketwire
May 18
Comment
AURORA, ON -- (Marketwire) -- 05/18/12 -- Helix BioPharma Corp. (TSX: HBP) (NYSE Amex: HBP) (FRANKFURT: HBP), a developer of biopharmaceutical drug candidates for the prevention and treatment of cancer, today announced that the German regulatory
Marketwire
May 14
Comment
AURORA, ON -- (Marketwire) -- 05/14/12 -- Helix BioPharma Corp. (TSX: HBP) (NYSE Amex: HBP) (FRANKFURT: HBP), a developer of biopharmaceutical drug candidates for the prevention and treatment of cancer, today announced that clinical site initiation
Marketwire
May 7
Comment
AURORA, ONTARIO -- (Marketwire) -- 05/07/12 -- Helix BioPharma Corp. (TSX:HBP)(NYSE Amex:HBP)(FRANKFURT:HBP) announced today that it has obtained an Order of the Ontario Superior Court of Justice approving the settlement that Helix entered into with
Marketwire
May 3
Comment
AURORA, ON -- (Marketwire) -- 05/03/12 -- Helix BioPharma Corp. (TSX: HBP) (NYSE Amex: HBP) (FRANKFURT: HBP) announced today that, in compliance with applicable corporate law, it is seeking an Order of the Ontario Superior Court of Justice approving
Marketwire
Apr 9
Comment
SAN FRANCISCO, CA -- (Marketwire) -- 04/09/12 -- Vista Partners ("Vista") announced today that it published its FREE macroeconomic/small cap oriented monthly newsletter for the month of April. Each monthly newsletter from Vista contains macroeconomic
Marketwire
Apr 5
Comment
AURORA, ON -- (Marketwire) -- 04/05/12 -- Helix BioPharma Corp. (TSX: HBP) (NYSE Amex: HBP) (FRANKFURT: HBP), announced today that its recently reconstituted Board of Directors has met and commenced a detailed review with independent advisors of the
Marketwire
Mar 14
Comment
AURORA, ON -- (Marketwire) -- 03/14/12 -- Helix BioPharma Corp. (TSX: HBP) (NYSE Amex: HBP) (FRANKFURT: HBP) (the "Company" or "Helix") announces that it has settled the proxy contest with the Concerned Shareholders named in the Dissident Proxy
Benzinga
Mar 1
Comment
Helix BioPharma Corp. (NYSE: HBP) today announced that an L-DOS47 scientific presentation will be made at the Second Annual IBC Conference on Analytical Technologies Biotherapeutic Development in San Diego, California, USA.
The presentation...
Marketwire
Jan 27
Comment
TORONTO, ONTARIO -- (Marketwire) -- 01/27/12 -- A group of concerned shareholders ("Concerned Shareholders") of Helix BioPharma Corp. ("Helix"), led by Mr. Zbigniew Lobacz, a significant shareholder, thank fellow shareholders for the overwhelming
Benzinga
Jan 23
Comment
Helix BioPharma Corp. (NYSE: HBP) is pleased to announce that Institutional Shareholder Services has recommended that shareholders vote FOR the slate of directors nominated by management, which includes Jack M. Kay, W. Thomas Hodgson, Donald H....
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS
 |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
References
| |||||||
